Q Huang1, Q Wang1, S Zhang1, S Jiang1, L Zhao1, L Yu2, M Hultström3,4, A Patzak5, L Li6, C S Wilcox6, E Y Lai7. 1. Department of Physiology, Zhejiang University School of Medicine, Hangzhou, China. 2. College of Life Sciences, Zhejiang University, Hangzhou, China. 3. Integrative Physiology, Department of Medical Cell Biology, Uppsala University, Uppsala, Sweden. 4. Anesthesia and Intensive Care Medicine, Department of Surgical Sciences, Uppsala University, Uppsala, Sweden. 5. Institute of Vegetative Physiology, Charité-Universitätsmedizin Berlin, Berlin, Germany. 6. Department of Medicine, Division of Nephrology and Hypertension, Hypertension, Kidney and Vascular Research Center, Georgetown University, Washington, DC, USA. 7. Department of Physiology, Zhejiang University School of Medicine, Hangzhou, China. laienyin@zju.edu.cn.
Abstract
AIM: Renal ischaemia-reperfusion injury (IRI) increases angiotensin II (Ang II) and reactive oxygen species (ROS) that are potent modulators of vascular function. However, the roles of individual ROS and their interaction with Ang II are not clear. Here we tested the hypothesis that IRI modulates renal afferent arteriolar responses to Ang II via increasing superoxide (O2-) or hydrogen peroxide (H2 O2 ). METHODS: Renal afferent arterioles were isolated and perfused from C57BL/6 mice 24 h after IRI or sham surgery. Responses to Ang II or noradrenaline were assessed by measuring arteriolar diameter. Production of H2 O2 and O2- was assessed in afferent arterioles and renal cortex. Activity of SOD and catalase, and mRNA expressions of Ang II receptors were assessed in pre-glomerular arterioles and renal cortex. RESULTS: Afferent arterioles from mice after IRI had a reduced maximal contraction to Ang II (-27±2 vs. -42±1%, P < 0.001), but retained a normal contraction to noradrenaline. Arterioles after IRI had a 38% increase in H2 O2 (P < 0.001) and a 45% decrease in catalase activity (P < 0.01). Contractions were reduced in normal arterioles after incubation with H2 O2 (-22±2 vs. -42±1%, P < 0.05) similar to the effects of IRI. However, the impaired contractions were normalized by incubation with PEG catalase despite a reduced AT1 R expression. CONCLUSIONS: Renal IRI in mice selectively impairs afferent arteriolar responses to Ang II because of H2 O2 accumulation that is caused by a reduced catalase activity. This could serve to buffer the effect of Ang II after IRI and may be a protective mechanism.
AIM: Renal ischaemia-reperfusion injury (IRI) increases angiotensin II (Ang II) and reactive oxygen species (ROS) that are potent modulators of vascular function. However, the roles of individual ROS and their interaction with Ang II are not clear. Here we tested the hypothesis that IRI modulates renal afferent arteriolar responses to Ang II via increasing superoxide (O2-) or hydrogen peroxide (H2 O2 ). METHODS: Renal afferent arterioles were isolated and perfused from C57BL/6 mice 24 h after IRI or sham surgery. Responses to Ang II or noradrenaline were assessed by measuring arteriolar diameter. Production of H2 O2 and O2- was assessed in afferent arterioles and renal cortex. Activity of SOD and catalase, and mRNA expressions of Ang II receptors were assessed in pre-glomerular arterioles and renal cortex. RESULTS: Afferent arterioles from mice after IRI had a reduced maximal contraction to Ang II (-27±2 vs. -42±1%, P < 0.001), but retained a normal contraction to noradrenaline. Arterioles after IRI had a 38% increase in H2 O2 (P < 0.001) and a 45% decrease in catalase activity (P < 0.01). Contractions were reduced in normal arterioles after incubation with H2 O2 (-22±2 vs. -42±1%, P < 0.05) similar to the effects of IRI. However, the impaired contractions were normalized by incubation with PEGcatalase despite a reduced AT1 R expression. CONCLUSIONS: Renal IRI in mice selectively impairs afferent arteriolar responses to Ang II because of H2 O2 accumulation that is caused by a reduced catalase activity. This could serve to buffer the effect of Ang II after IRI and may be a protective mechanism.
Authors: En Yin Lai; Glenn Solis; Zaiming Luo; Mattias Carlstrom; Kathryn Sandberg; Steven Holland; Anton Wellstein; William J Welch; Christopher S Wilcox Journal: Hypertension Date: 2011-12-19 Impact factor: 10.190
Authors: Sergey V Brodsky; Tokunori Yamamoto; Tetsuhiro Tada; Byungsoo Kim; Jun Chen; Fumihiko Kajiya; Michael S Goligorsky Journal: Am J Physiol Renal Physiol Date: 2002-06
Authors: Armin Just; Andrea J M Olson; Christina L Whitten; William J Arendshorst Journal: Am J Physiol Heart Circ Physiol Date: 2006-09-01 Impact factor: 4.733
Authors: T Matoba; H Shimokawa; M Nakashima; Y Hirakawa; Y Mukai; K Hirano; H Kanaide; A Takeshita Journal: J Clin Invest Date: 2000-12 Impact factor: 14.808
Authors: Lingli Li; En Yin Lai; Zaiming Luo; Glenn Solis; Margarida Mendonca; Kathy K Griendling; Anton Wellstein; William J Welch; Christopher S Wilcox Journal: Hypertension Date: 2018-11 Impact factor: 10.190
Authors: Shan Jiang; Ximing Wang; Jin Wei; Gensheng Zhang; Jie Zhang; Peng Xie; Lan Xu; Lei Wang; Liang Zhao; Lingli Li; Christopher S Wilcox; Jianghua Chen; En Yin Lai; Ruisheng Liu Journal: Hypertension Date: 2019-09-16 Impact factor: 10.190
Authors: Wenguang Feng; Colton E Remedies; Ijeoma E Obi; Stephen R Aldous; Samia I Meera; Paul W Sanders; Edward W Inscho; Zhengrong Guan Journal: Am J Physiol Renal Physiol Date: 2021-01-25
Authors: Diana Braun; Christa Zollbrecht; Stefanie Dietze; Rudolf Schubert; Stefan Golz; Holger Summer; Pontus B Persson; Mattias Carlström; Marion Ludwig; Andreas Patzak Journal: Front Physiol Date: 2018-05-03 Impact factor: 4.566